This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pfaller, M. A.
Right arrow Articles by Coffmann, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pfaller, M. A.
Right arrow Articles by Coffmann, S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 1995, 1094-1097, Vol 33, No. 5
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870

MA Pfaller, SA Messer and S Coffmann
Department of Pathology, University of Iowa College of Medicine, Iowa City 52242, USA.

A study to compare three different methods for reading MIC endpoints tested by the broth microdilution modification of the National Committee for Clinical Laboratory Standards (Villanova, Pa.) reference method was conducted. MICs of amphotericin B, flucytosine, fluconazole, itraconazole, and a new triazole, D0870, were determined for five reference yeast strains and 100 clinical isolates of Candida spp. MICs were read visually according to National Committee for Clinical Laboratory Standards guidelines from microdilution trays that had been (VS) and had not been (V) shaken. MICs were also determined spectrophotometrically (SP) at 492 nm. SP endpoints were determined as the concentrations resulting in a > or = 50% inhibition of growth (flucytosine and azoles) and a > or = 90% inhibition of growth (amphotericin B) relative to control growth. The five reference strains were tested nine times each against all five antifungal agents, and the MIC results for each reading method were compared with a 3-log2 dilution reference range determined by the macrodilution (M27-P) method. Overall, 84 to 100% of the MICs determined by V, 93 to 100% of those determined by VS, and 89 to 100% of those determined by SP fell within the 3-log2 dilution reference range for each reference strain and antifungal agent. Reproducibility was 99% for V and SP and 98% for VS. Agreement among the three methods of reading ranged from 97 to 99%. Excellent agreement among reading methods was also observed for all antifungal agents when tested against 100 clinical isolates.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:

  • Dannaoui, E., Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Verweij, P. E., the Eurofung Network, (2003). In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 51: 45-52 [Abstract] [Full Text]  
  • Liao, R. S., Rennie, R. P., Talbot, J. A. (2002). Comparative Evaluation of a New Fluorescent Carboxyfluorescein Diacetate-Modified Microdilution Method for Antifungal Susceptibility Testing of Candida albicans Isolates. Antimicrob. Agents Chemother. 46: 3236-3242 [Abstract] [Full Text]  
  • Arthington-Skaggs, B. A., Lee-Yang, W., Ciblak, M. A., Frade, J. P., Brandt, M. E., Hajjeh, R. A., Harrison, L. H., Sofair, A. N., Warnock, a. D. W. (2002). Comparison of Visual and Spectrophotometric Methods of Broth Microdilution MIC End Point Determination and Evaluation of a Sterol Quantitation Method for In Vitro Susceptibility Testing of Fluconazole and Itraconazole against Trailing and Nontrailing Candida Isolates. Antimicrob. Agents Chemother. 46: 2477-2481 [Abstract] [Full Text]  
  • Liu, Y., Tortora, G., Ryan, M. E., Lee, H.-M., Golub, L. M. (2002). Potato Dextrose Agar Antifungal Susceptibility Testing for Yeasts and Molds: Evaluation of Phosphate Effect on Antifungal Activity of CMT-3. Antimicrob. Agents Chemother. 46: 1455-1461 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L., Huynh, H., Hollis, R. J. (2002). Clinical Evaluation of a Frozen Commercially Prepared Microdilution Panel for Antifungal Susceptibility Testing of Seven Antifungal Agents, Including the New Triazoles Posaconazole, Ravuconazole, and Voriconazole. J. Clin. Microbiol. 40: 1694-1697 [Abstract] [Full Text]  
  • Vandenbossche, I., Vaneechoutte, M., Vandevenne, M., De Baere, T., Verschraegen, G. (2002). Susceptibility Testing of Fluconazole by the NCCLS Broth Macrodilution Method, E-Test, and Disk Diffusion for Application in the Routine Laboratory. J. Clin. Microbiol. 40: 918-921 [Abstract] [Full Text]  
  • Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Warnock, D. W. (2001). Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clin. Microbiol. Rev. 14: 643-658 [Abstract] [Full Text]  
  • Rambali, B., Fernandez, J. A., Van Nuffel, L., Woestenborghs, F., Baert, L., Massart, D. L., Odds, F. C. (2001). Susceptibility testing of pathogenic fungi with itraconazole: a process analysis of test variables. J Antimicrob Chemother 48: 163-177 [Abstract] [Full Text]  
  • Liao, R. S., Rennie, R. P., Talbot, J. A. (2001). Novel Fluorescent Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida albicans. J. Clin. Microbiol. 39: 2708-2712 [Abstract] [Full Text]  
  • Weig, M., Müller, F.-M. C. (2001). Synergism of Voriconazole and Terbinafine against Candida albicans Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis. Antimicrob. Agents Chemother. 45: 966-968 [Abstract] [Full Text]  
  • St-Germain, G., Laverdière, M., Pelletier, R., Bourgault, A.-M., Libman, M., Lemieux, C., Noël, G. (2001). Prevalence and Antifungal Susceptibility of 442 Candida Isolates from Blood and Other Normally Sterile Sites: Results of a 2-Year (1996 to 1998) Multicenter Surveillance Study in Quebec, Canada. J. Clin. Microbiol. 39: 949-953 [Abstract] [Full Text]  
  • Cuenca-Estrella, M., Díaz-Guerra, T. M., Mellado, E., Rodríguez-Tudela, J. L. (2001). Influence of Glucose Supplementation and Inoculum Size on Growth Kinetics and Antifungal Susceptibility Testing of Candida spp.. J. Clin. Microbiol. 39: 525-532 [Abstract] [Full Text]  
  • Vargas, K., Messer, S. A., Pfaller, M., Lockhart, S. R., Stapleton, J. T., Hellstein, J., Soll, D. R. (2000). Elevated Phenotypic Switching and Drug Resistance of Candida albicans from Human Immunodeficiency Virus-Positive Individuals prior to First Thrush Episode. J. Clin. Microbiol. 38: 3595-3607 [Abstract] [Full Text]  
  • Llop, C., Pujol, I., Aguilar, C., Sala, J., Riba, D., Guarro, J. (2000). Comparison of Three Methods of Determining MICs for Filamentous Fungi Using Different End Point Criteria and Incubation Periods. Antimicrob. Agents Chemother. 44: 239-242 [Abstract] [Full Text]  
  • Lozano-Chiu, M., Arikan, S., Paetznick, V. L., Anaissie, E. J., Rex, J. H. (1999). Optimizing Voriconazole Susceptibility Testing of Candida: Effects of Incubation Time, Endpoint Rule, Species of Candida, and Level of Fluconazole Susceptibility. J. Clin. Microbiol. 37: 2755-2759 [Abstract] [Full Text]  
  • Espinel-Ingroff, A., Pfaller, M., Messer, S. A., Knapp, C. C., Killian, S., Norris, H. A., Ghannoum, M. A. (1999). Multicenter Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory Standards M27-A Reference Method for Testing Clinical Isolates of Common and Emerging Candida spp., Cryptococcus spp., and Other Yeasts and Yeast-Like Organisms. J. Clin. Microbiol. 37: 591-595 [Abstract] [Full Text]  
  • Nguyen, M. H., Yu, C. Y. (1999). Influence of Incubation Time, Inoculum Size, and Glucose Concentrations on Spectrophotometric Endpoint Determinations for Amphotericin B, Fluconazole, and Itraconazole. J. Clin. Microbiol. 37: 141-145 [Abstract] [Full Text]  
  • Pfaller, M. A., Arikan, S., Lozano-Chiu, M., Chen, Y.-S., Coffman, S., Messer, S. A., Rennie, R., Sand, C., Heffner, T., Rex, J. H., Wang, J., Yamane, N. (1998). Clinical Evaluation of the ASTY Colorimetric Microdilution Panel for Antifungal Susceptibility Testing. J. Clin. Microbiol. 36: 2609-2612 [Abstract] [Full Text]  
  • Hawser, S. P., Norris, H., Jessup, C. J., Ghannoum, M. A. (1998). Comparison of a 2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2H-Tetrazolium Hydroxide (XTT) Colorimetric Method with the Standardized National Committee for Clinical Laboratory Standards Method of Testing Clinical Yeast Isolates for Susceptibility to Antifungal Agents. J. Clin. Microbiol. 36: 1450-1452 [Abstract] [Full Text]  
  • Revankar, S., Kirkpatrick, W., McAtee, R., Fothergill, A., Redding, S., Rinaldi, M., Patterson, T. (1998). Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method [In Process Citation]. J. Clin. Microbiol. 36: 153-156 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»